0001225208-20-007361.txt : 20200511
0001225208-20-007361.hdr.sgml : 20200511
20200511141028
ACCESSION NUMBER: 0001225208-20-007361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200508
FILED AS OF DATE: 20200511
DATE AS OF CHANGE: 20200511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALLAHUE KIERAN
CENTRAL INDEX KEY: 0001308428
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 20864040
MAIL ADDRESS:
STREET 1: 7530 DRAPER AVENUE
STREET 2: SUITE 6
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER NAME:
FORMER CONFORMED NAME: Gallahue Kieran
DATE OF NAME CHANGE: 20041110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2020-05-08
0001099800
Edwards Lifesciences Corp
EW
0001308428
GALLAHUE KIERAN
ONE EDWARDS WAY
IRVINE
CA
92614
1
Common Stock
2020-05-07
5
G
0
1737.0000
0.0000
D
0.0000
D
Common Stock
2020-05-08
4
A
0
1101.0000
0.0000
A
1101.0000
D
Common Stock
2020-05-08
4
A
0
345.0000
0.0000
A
1446.0000
D
Common Stock
2020-05-07
5
G
0
1737.0000
0.0000
A
17471.0000
I
By Trust
These restricted stock units were granted on May 8, 2020 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on Issuer's Board.
This restricted stock was granted on May 8, 2020 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2020-05-11